Targeted Iron Oxide Particles for In Vivo Magnetic Resonance Detection of Atherosclerotic Lesions With Antibodies Directed to Oxidation-Specific Epitopes

Abstract
No abstract available
Funding Information
  • National Heart, Lung, and Blood Institute (R01 HL71021, R01 HL78667)
  • National Institute of Biomedical Imaging and Bioengineering (R01 EB009638)
  • Fondation Leducq
  • National Institutes of Health (R21 HL091399-01A2)